1sec.ai

Tag

#biotech

Every item tagged biotech, newest first.

3 items

GPT-5 lowers the cost of cell-free protein synthesis

Researchers combined GPT-5 with Ginkgo Bioworks' cloud automation to optimize cell-free protein synthesis, achieving a 40% reduction in costs. This integration demonstrates the potential for AI-driven experimentation to improve efficiency in biotech applications. You can apply similar approaches to streamline your own workflows. The results highlight the value of combining AI with automation in scientific research.

Key takeaways
  • GPT-5 reduced cell-free protein synthesis costs by 40%.
  • AI-driven closed-loop experimentation improved biotech efficiency.
  • Automation and AI can be combined for scientific research benefits.
otherAug 7

How Amgen uses GPT-5

Amgen is using GPT-5 to improve research and development processes. The company is exploring applications in drug discovery and clinical trials. Builders can learn from Amgen's experience in integrating GPT-5 for biotech research. Amgen's work with GPT-5 showcases potential applications in the biotech industry.

Key takeaways
  • Amgen is using GPT-5 for drug discovery and clinical trials.
  • GPT-5 is being used to improve research and development processes.
  • Amgen's work with GPT-5 has implications for the biotech industry.
otherJun 18

Preparing for future AI risks in biology

OpenAI is proactively assessing AI capabilities and implementing safeguards to mitigate biosecurity risks associated with advanced AI in biology and medicine. The company recognizes AI's potential to transform these fields but also acknowledges the need to prevent misuse. Builders should consider the implications of AI in biology and the importance of safeguards. OpenAI's efforts aim to balance innovation with risk management.

Key takeaways
  • OpenAI assessing AI biosecurity risks in biology.
  • Implementing safeguards to prevent AI misuse.
  • AI transforming biology and medicine.